Annual D&A
$20.25 M
+$2.23 M+12.38%
31 December 2023
Summary:
Lyell Immunopharma annual depreciation & amortization is currently $20.25 million, with the most recent change of +$2.23 million (+12.38%) on 31 December 2023. During the last 3 years, it has risen by +$15.96 million (+371.59%). LYEL annual D&A is now at all-time high.LYEL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$4.68 M
-$221.00 K-4.51%
30 September 2024
Summary:
Lyell Immunopharma quarterly depreciation & amortization is currently $4.68 million, with the most recent change of -$221.00 thousand (-4.51%) on 30 September 2024. Over the past year, it has dropped by -$424.00 thousand (-8.31%). LYEL quarterly D&A is now -8.31% below its all-time high of $5.10 million, reached on 30 September 2023.LYEL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$19.66 M
-$424.00 K-2.11%
30 September 2024
Summary:
Lyell Immunopharma TTM depreciation & amortization is currently $19.66 million, with the most recent change of -$424.00 thousand (-2.11%) on 30 September 2024. Over the past year, it has dropped by -$572.00 thousand (-2.83%). LYEL TTM D&A is now -2.90% below its all-time high of $20.25 million, reached on 31 December 2023.LYEL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYEL Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.4% | -8.3% | -2.8% |
| 3 y3 years | +371.6% | +14.4% | +87.1% |
| 5 y5 years | - | - | - |
LYEL Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +371.6% | -8.3% | +14.4% | -2.9% | +87.1% |
| 5 y | 5 years | at high | +1512.3% | -8.3% | +503.1% | -2.9% | +2433.8% |
| alltime | all time | at high | +1512.3% | -8.3% | +503.1% | -2.9% | +2433.8% |
Lyell Immunopharma Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.68 M(-4.5%) | $19.66 M(-2.1%) |
| June 2024 | - | $4.90 M(-2.4%) | $20.09 M(-0.8%) |
| Mar 2024 | - | $5.02 M(-0.7%) | $20.25 M(-0.0%) |
| Dec 2023 | $20.25 M(+12.4%) | $5.06 M(-0.9%) | $20.25 M(+0.1%) |
| Sept 2023 | - | $5.10 M(+0.8%) | $20.23 M(+2.4%) |
| June 2023 | - | $5.06 M(+0.7%) | $19.75 M(+4.7%) |
| Mar 2023 | - | $5.03 M(-0.3%) | $18.86 M(+4.7%) |
| Dec 2022 | $18.02 M | $5.04 M(+9.1%) | $18.02 M(+2.7%) |
| Sept 2022 | - | $4.62 M(+10.8%) | $17.54 M(+3.1%) |
| June 2022 | - | $4.17 M(-0.4%) | $17.01 M(+7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $4.19 M(-8.3%) | $15.85 M(+16.4%) |
| Dec 2021 | $13.62 M(+217.3%) | $4.57 M(+11.6%) | $13.62 M(+29.6%) |
| Sept 2021 | - | $4.09 M(+35.9%) | $10.51 M(+39.7%) |
| June 2021 | - | $3.01 M(+53.7%) | $7.52 M(+37.4%) |
| Mar 2021 | - | $1.96 M(+34.8%) | $5.48 M(+27.5%) |
| Dec 2020 | $4.29 M(+241.9%) | - | - |
| Dec 2020 | - | $1.45 M(+31.5%) | $4.29 M(+51.1%) |
| Sept 2020 | - | $1.10 M(+14.8%) | $2.84 M(+63.5%) |
| June 2020 | - | $962.00 K(+24.0%) | $1.74 M(+124.0%) |
| Mar 2020 | - | $776.00 K | $776.00 K |
| Dec 2019 | $1.26 M | - | - |
FAQ
- What is Lyell Immunopharma annual depreciation & amortization?
- What is the all time high annual D&A for Lyell Immunopharma?
- What is Lyell Immunopharma annual D&A year-on-year change?
- What is Lyell Immunopharma quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly D&A year-on-year change?
- What is Lyell Immunopharma TTM depreciation & amortization?
- What is the all time high TTM D&A for Lyell Immunopharma?
- What is Lyell Immunopharma TTM D&A year-on-year change?
What is Lyell Immunopharma annual depreciation & amortization?
The current annual D&A of LYEL is $20.25 M
What is the all time high annual D&A for Lyell Immunopharma?
Lyell Immunopharma all-time high annual depreciation & amortization is $20.25 M
What is Lyell Immunopharma annual D&A year-on-year change?
Over the past year, LYEL annual depreciation & amortization has changed by +$2.23 M (+12.38%)
What is Lyell Immunopharma quarterly depreciation & amortization?
The current quarterly D&A of LYEL is $4.68 M
What is the all time high quarterly D&A for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly depreciation & amortization is $5.10 M
What is Lyell Immunopharma quarterly D&A year-on-year change?
Over the past year, LYEL quarterly depreciation & amortization has changed by -$424.00 K (-8.31%)
What is Lyell Immunopharma TTM depreciation & amortization?
The current TTM D&A of LYEL is $19.66 M
What is the all time high TTM D&A for Lyell Immunopharma?
Lyell Immunopharma all-time high TTM depreciation & amortization is $20.25 M
What is Lyell Immunopharma TTM D&A year-on-year change?
Over the past year, LYEL TTM depreciation & amortization has changed by -$572.00 K (-2.83%)